 Home > Active Ingredient News > Antitumor Therapy > NEJM: The effect of anti-B cell maturation antigen CAR-T cell therapy bb2121 in the treatment of multiple myeloma

NEJM: The effect of anti-B cell maturation antigen CAR-T cell therapy bb2121 in the treatment of multiple myeloma

 Last Update: 2021-05-20
 Source: Internet
 Author: User

Tags

anti fungals

1 4 socket

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

bb2121 is a chimeric antigen receptor (CAR) T cell therapy against B cell maturation antigen (BCMA).

The study included patients with relapsed or refractory multiple myeloma.

⁶⁶⁶⁶⁶⁶Immunity

The study reported the results of 33 consecutive patients who received the earliest input of bb2121.

During the trial, a total of 25 patients (76%) developed cytokine release syndrome, of which 23 cases (70%) were grade 1 or 2, and 2 cases (6%) were grade 3.

The median progression-free survival was 11.

In summary, the study reported the preliminary toxicity characteristics of patients with relapsed or refractory multiple myeloma after receiving cellular immunotherapy targeting BCMA, and the study confirmed the anti-tumor activity of bb2121.

Original source:

Noopur Raje, et al.

ncbi.
nlm.
nih.
gov/31042825/" target="_blank" rel="noopener">Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Imatinib mesylate

CAS No.: 220127-57-1

Pharmacy Grade

$1/MT EXW

N-Desmethyl Imatinib 99%

CAS No.: 404844-02-6

Pharma Grade

$1/MT FOB

High purity Gefitinib 98% with best price 184475-35-2 and Gefitinib raw material

CAS No.: 184475-35-2

Pharmacy Grade

$8.8-10/MT FOB

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.